Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications
Gastric cancer (GC) is the fifth most common malignant tumor that imposes heavily public health burdens worldwide. Systemic therapies for gastric cancer (GC), such as chemotherapy, targeted therapy, and immunotherapy, have undergone significant advancements. Nevertheless, the extensive application o...
Saved in:
| Main Authors: | ChengTao Wan, Jie Deng, Yu Zhu, Li Wan, Linyue Xu, Qiuyan Chen, Can Zou, Ju Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1549694/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy
by: Ying Xu, et al.
Published: (2025-04-01) -
Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
by: Yibo He, et al.
Published: (2025-03-01) -
Stanniocalcin-1 in tumor immunity: acts via macrophages
by: Lele Wang, et al.
Published: (2024-11-01) -
Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy
by: Yiting Xu, et al.
Published: (2025-05-01) -
Recent progress in the study of exosomes in the gastric cancer immune microenvironment
by: Haibo Liu, et al.
Published: (2025-07-01)